Cargando…

Bayesian alternatives to null hypothesis significance testing in biomedical research: a non-technical introduction to Bayesian inference with JASP

BACKGROUND: Although null hypothesis significance testing (NHST) is the agreed gold standard in medical decision making and the most widespread inferential framework used in medical research, it has several drawbacks. Bayesian methods can complement or even replace frequentist NHST, but these method...

Descripción completa

Detalles Bibliográficos
Autor principal: Kelter, Riko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275319/
https://www.ncbi.nlm.nih.gov/pubmed/32503439
http://dx.doi.org/10.1186/s12874-020-00980-6
_version_ 1783542758259032064
author Kelter, Riko
author_facet Kelter, Riko
author_sort Kelter, Riko
collection PubMed
description BACKGROUND: Although null hypothesis significance testing (NHST) is the agreed gold standard in medical decision making and the most widespread inferential framework used in medical research, it has several drawbacks. Bayesian methods can complement or even replace frequentist NHST, but these methods have been underutilised mainly due to a lack of easy-to-use software. JASP is an open-source software for common operating systems, which has recently been developed to make Bayesian inference more accessible to researchers, including the most common tests, an intuitive graphical user interface and publication-ready output plots. This article provides a non-technical introduction to Bayesian hypothesis testing in JASP by comparing traditional tests and statistical methods with their Bayesian counterparts. RESULTS: The comparison shows the strengths and limitations of JASP for frequentist NHST and Bayesian inference. Specifically, Bayesian hypothesis testing via Bayes factors can complement and even replace NHST in most situations in JASP. While p-values can only reject the null hypothesis, the Bayes factor can state evidence for both the null and the alternative hypothesis, making confirmation of hypotheses possible. Also, effect sizes can be precisely estimated in the Bayesian paradigm via JASP. CONCLUSIONS: Bayesian inference has not been widely used by now due to the dearth of accessible software. Medical decision making can be complemented by Bayesian hypothesis testing in JASP, providing richer information than single p-values and thus strengthening the credibility of an analysis. Through an easy point-and-click interface researchers used to other graphical statistical packages like SPSS can seemlessly transition to JASP and benefit from the listed advantages with only few limitations.
format Online
Article
Text
id pubmed-7275319
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72753192020-06-08 Bayesian alternatives to null hypothesis significance testing in biomedical research: a non-technical introduction to Bayesian inference with JASP Kelter, Riko BMC Med Res Methodol Software BACKGROUND: Although null hypothesis significance testing (NHST) is the agreed gold standard in medical decision making and the most widespread inferential framework used in medical research, it has several drawbacks. Bayesian methods can complement or even replace frequentist NHST, but these methods have been underutilised mainly due to a lack of easy-to-use software. JASP is an open-source software for common operating systems, which has recently been developed to make Bayesian inference more accessible to researchers, including the most common tests, an intuitive graphical user interface and publication-ready output plots. This article provides a non-technical introduction to Bayesian hypothesis testing in JASP by comparing traditional tests and statistical methods with their Bayesian counterparts. RESULTS: The comparison shows the strengths and limitations of JASP for frequentist NHST and Bayesian inference. Specifically, Bayesian hypothesis testing via Bayes factors can complement and even replace NHST in most situations in JASP. While p-values can only reject the null hypothesis, the Bayes factor can state evidence for both the null and the alternative hypothesis, making confirmation of hypotheses possible. Also, effect sizes can be precisely estimated in the Bayesian paradigm via JASP. CONCLUSIONS: Bayesian inference has not been widely used by now due to the dearth of accessible software. Medical decision making can be complemented by Bayesian hypothesis testing in JASP, providing richer information than single p-values and thus strengthening the credibility of an analysis. Through an easy point-and-click interface researchers used to other graphical statistical packages like SPSS can seemlessly transition to JASP and benefit from the listed advantages with only few limitations. BioMed Central 2020-06-05 /pmc/articles/PMC7275319/ /pubmed/32503439 http://dx.doi.org/10.1186/s12874-020-00980-6 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Software
Kelter, Riko
Bayesian alternatives to null hypothesis significance testing in biomedical research: a non-technical introduction to Bayesian inference with JASP
title Bayesian alternatives to null hypothesis significance testing in biomedical research: a non-technical introduction to Bayesian inference with JASP
title_full Bayesian alternatives to null hypothesis significance testing in biomedical research: a non-technical introduction to Bayesian inference with JASP
title_fullStr Bayesian alternatives to null hypothesis significance testing in biomedical research: a non-technical introduction to Bayesian inference with JASP
title_full_unstemmed Bayesian alternatives to null hypothesis significance testing in biomedical research: a non-technical introduction to Bayesian inference with JASP
title_short Bayesian alternatives to null hypothesis significance testing in biomedical research: a non-technical introduction to Bayesian inference with JASP
title_sort bayesian alternatives to null hypothesis significance testing in biomedical research: a non-technical introduction to bayesian inference with jasp
topic Software
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275319/
https://www.ncbi.nlm.nih.gov/pubmed/32503439
http://dx.doi.org/10.1186/s12874-020-00980-6
work_keys_str_mv AT kelterriko bayesianalternativestonullhypothesissignificancetestinginbiomedicalresearchanontechnicalintroductiontobayesianinferencewithjasp